Zenas BioPharma, Inc. Deferred Tax Assets, Operating Loss Carryforwards, State and Local
Zenas BioPharma, Inc. (ZBIO) had Deferred Tax Assets, Operating Loss Carryforwards, State and Local of $210.40 million as of 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal · last filed 2026-03-16
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $210.40M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $65.00M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $0.00.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, State and Local |
|---|---|
| 2025-12-31 | $210.40M 10-K · filed 2026-03-16 |
| 2024-12-31 | $65.00M 10-K · filed 2026-03-16 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-11 |